திமிங்கிலம் மேலாண்மை நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from திமிங்கிலம் மேலாண்மை நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In திமிங்கிலம் மேலாண்மை நிறுவனம் Today - Breaking & Trending Today

Longevity Acquisition Corporation Announces 4D pharma Update on Oncology Program

Longevity Acquisition Corporation Announces 4D pharma Update on Oncology Program
News provided by
Share this article
Share this article
NEW YORK, Feb. 3, 2021 /PRNewswire/ Longevity Acquisition Corporation (NASDAQ: LOAC) (the Company ), a publicly-traded special purpose acquisition company, announced today that on February 3, 2021, 4D pharma plc (AIM: DDDD) ( 4D pharma ), a pharmaceutical company leading the development of Live Biotherapeutic products ( LBPs ) - a novel class of drug derived from the microbiome, and a business combination target of LOAC, has announced progress on activities in its development program for lead immuno-oncology single strain Live Biotherapeutic candidate MRx0518.
4D pharma has continued to make excellent progress with the MRx0518 development program on multiple fronts. We have generated additional safety and efficacy data, building on the positive data from both the monotherapy and KEYTRUDA combination studies last year. This ....

United Kingdom , United States , City Of , Karen Smith , Alex Stevenson , Matthew Chen , Purpose Acquisition Company , Whale Management Corporation , University Of Texas Md Anderson Cancer Center , Exchange Commission On , Society For Immunotherapy Of Cancer , Yongda International Tower No , Acquisition Corporation , Merck Co Inc , Advantage Proxy Inc , Longevity Acquisition Corporation , Imperial College London , Securities Exchange , Prnewswire Longevity Acquisition Corporation , Chief Scientific Officer , Annual Meeting , Imperial College , Coordinating Investigator , Cancer Center , Special Purpose Acquisition Company , Exchange Commission ,

Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson's Progression Markers Initiative

Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson s Progression Markers Initiative
News provided by
Share this article
Share this article
NEW YORK, Dec. 21, 2020 /PRNewswire/ Longevity Acquisition Corporation (NASDAQ: LOAC) (the Company ), a publicly-traded special purpose acquisition company, announced today that on December 18, 2020, 4D pharma plc (AIM: DDDD) ( 4D pharma ), a pharmaceutical company leading the development of Live Biotherapeutic products ( LBPs ) - a novel class of drug derived from the microbiome, and a business combination target of LOAC, has joined the Parkinson s Progression Markers Initiative ( PPMI ) as an industry partner. PPMI is a landmark study sponsored by The Michael J. Fox Foundation to better understand Parkinson s disease and accelerate the development of new treatments. ....

United States , Karen Smith , Alex Stevenson , Matthew Chen , Sohini Chowdhury , Purpose Acquisition Company , Whale Management Corporation , Exchange Commission On , Parkinson Progression Markers Initiative , Yongda International Tower No , Acquisition Corporation , Merck Co Inc , Longevity Acquisition Corporation , Advantage Proxy Inc , Securities Exchange , Michaelj Fox Foundation , Prnewswire Longevity Acquisition Corporation , Progression Markers Initiative , Partner Scientific Advisory Board , Advisory Board , Chief Scientific Officer , Progression Markers , Scientific Advisory Board , Special Purpose Acquisition Company , Exchange Commission , Irritable Bowel Syndrome ,

Longevity Acquisition Corporation Regains Compliance with Nasdaq Listing Requirement

Longevity Acquisition Corporation Regains Compliance with Nasdaq Listing Requirement
News provided by
Share this article
Share this article
NEW YORK, Dec. 11, 2020 /PRNewswire/ Longevity Acquisition Corporation (NASDAQ: LOAC) (the Company ), a publicly-traded special purpose acquisition company, announced today that on December 10, 2020, the Company received a letter from the Listing Qualifications Department of The NASDAQ Stock Market ( Nasdaq ), confirming that the Company had regained compliance with Nasdaq Listing Rule 5550(a)(3) which requires companies listed on the NASDAQ Capital Market to have at least 300 public holders for continued listing (the Minimum Public Holders Rule ).
As previously disclosed by the Company in its Current Report on Form 8-K dated September 2, 2020, the Company was notified by Listing Qualification Department of Nasdaq that it did not comply with the Minimum Public Holders Rule. Based on the Company s submissions to Nasdaq ....

Matthew Chen , Purpose Acquisition Company , Whale Management Corporation , Exchange Commission On , Sd Pharma , Listing Qualifications Department , Longevity Acquisition Corporation , Securities Exchange , Listing Qualifications Department Of Nasdaq , Listing Qualification Department Of Nasdaq , Prnewswire Longevity Acquisition Corporation , Acquisition Corporation , Nasdaq Listing Rule , Public Holders , Current Report , Listing Qualification Department , Minimum Public Holders , Special Purpose Acquisition Company , Exchange Commission , Securities Litigation Reform Act , Securities Act , Securities Exchange Act , மேத்யூ சென் , நோக்கம் கையகப்படுத்தல் நிறுவனம் , திமிங்கிலம் மேலாண்மை நிறுவனம் , பரிமாற்றம் தரகு ஆன் ,